VAXIL WAS FOUNDED BY WEIZMANN INSTITUTE SCIENTISTS, ISRAEL'S TOP RESEARCH UNIVERSITY, IN ORDER TO PROVIDE AN ALTOGETHER NOVEL APPROACH TO IMMUNOTHERAPY. VAXIL HAS DILIGENTLY ADVANCED ITS IMMUNOTHERAPY PLATFORM AND PUBLISHED ITS RESEARCH AND CLINICAL RESULTS IN TOP MEDICAL JOURNALS.
VAXIL CANADA
FIRST CANADIAN PLACE, 34TH FLOOR, 100 KING ST. WEST, TORONTO, ONTARIO. M5X 1A9 CANADA (CARE OF VAXIL CORPORATE COUNSEL BENNETT JONES LLP)